MiniMed Completes Separation from Medtronic
Key Highlights
- ➤MiniMed (MMED) completed its separation from Medtronic (MDT), becoming fully independent.
- ➤Medtronic accepted 55,032,401 shares in exchange for 252,813,348 MiniMed shares.
- ➤Exchange offer was 5.4x subscribed.
- ➤Medtronic no longer holds an equity stake in MiniMed.
Expert Statements
Que Dallara, Chief Executive Officer of MiniMed
“Today marks the completion of our separation from Medtronic and a significant milestone for MiniMed. We are grateful to Medtronic for its partnership and support in reaching this point. As an independent company, we have the freedom to make the decisions we believe are right for our business and the people we serve, and the responsibility to see those decisions through. Our focus now is to put that independence to work and continue advancing what is possible in diabetes care.”
NORTHRIDGE, Calif., Oct. 15, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) today announced the completion of its separation from Medtronic plc ("Medtronic"; NYSE: MDT), marking its first day as a fully independent company.
"Today marks the completion of our separation from Medtronic and a significant milestone for MiniMed," said Que Dallara, Chief Executive Officer of MiniMed. "We are grateful to Medtronic for its partnership and support in reaching this point. As an independent company, we have the freedom to make the decisions we believe are right for our business and the people we serve, and the responsibility to see those decisions through. Our focus now is to put that independence to work and continue advancing what is possible in diabetes care."
Get started
Create a free account to read the full story.